This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutman, A.
Right arrow Articles by Wilson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutman, A.
Right arrow Articles by Wilson, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 1998, p. 772-778, Vol. 42, No. 4
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Effect of Dirithromycin on Haemophilus influenzae Infection of the Respiratory Mucosa

Andrew Rutman,1 Ruth Dowling,1 Peter Wills,1 Charles Feldman,2 Peter J. Cole,1 and Robert Wilson1,*

Host Defence Unit, Imperial College of Science, Technology and Medicine, National Heart and Lung Institute, London, United Kingdom,1 and Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa2

Received 10 July 1997/Returned for modification 22 October 1997/Accepted 18 January 1998

Macrolides have properties other than their antibiotic action which may benefit patients with airway infections. We have investigated the effect of dirithromycin (0.125 to 8.0 µg/ml) on the interaction of Haemophilus influenzae with respiratory mucosa in vitro using human nasal epithelium, adenoid tissue, and bovine trachea. Dirithromycin did not affect the ciliary beat frequency of the nasal epithelium or the transport of mucus on bovine trachea, but dirithromycin (1 µg/ml) did reduce the slowing of the ciliary beat frequency and the damage to the nasal epithelium caused by H. influenzae broth culture filtrate. Amoxicillin (2 µg/ml) did not reduce the effects of the H. influenzae broth culture filtrate. H. influenzae infection of the organ cultures for 24 h caused mucosal damage and the loss of ciliated cells. Bacteria adhered to damaged epithelium and to a lesser extent to mucus and unciliated cells. Incubation of H. influenzae with dirithromycin at sub-MICs (0.125 and 0.5 µg/ml) prior to infection of the organ cultures did not reduce the mucosal damage caused by bacterial infection. By contrast, incubation of adenoid tissue with dirithromycin (0.125 to 1.0 µg/ml) for 4 h prior to assembling the organ culture reduced the mucosal damage caused by subsequent H. influenzae infection by as much as 50%. The number of bacteria adherent to the mucosa was reduced, although the tissue that had been incubated with dirithromycin (0.125 and 0.5 µg/ml) did not inhibit bacterial growth. This was achieved by a reduction in the amount of damaged epithelium to which H. influenzae adhered and a reduction in the density of bacteria adhering to mucus. We conclude that dirithromycin at concentrations achievable in vivo markedly reduces the mucosal damage caused by H. influenzae infection due to a cytoprotective effect.


* Corresponding author. Mailing address: Host Defence Unit, National Heart and Lung Institute, Emmanuel Kaye Bldg., Manresa Rd., London SW3 6LR, United Kingdom. Phone: 44 171 351 8337. Fax: 44 171 351 8338. E-mail: r.b.dowling{at}ic.ac.uk.


Antimicrobial Agents and Chemotherapy, April 1998, p. 772-778, Vol. 42, No. 4
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • McNeilly, T. N., Tennant, P., Lujan, L., Perez, M., Harkiss, G. D. (2007). Differential infection efficiencies of peripheral lung and tracheal tissues in sheep infected with Visna/maedi virus via the respiratory tract. J. Gen. Virol. 88: 670-679 [Abstract] [Full Text]  
  • Wilson, R. (2001). Bacteria, antibiotics and COPD. Eur Respir J 17: 995-1007 [Abstract] [Full Text]  
  • Wilson, R., Kubin, R., Ballin, I., Deppermann, K.-M., Bassaris, H. P., Leophonte, P., Schreurs, A. J. M., Torres, A., Sommerauer, B. (1999). Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 44: 501-513 [Abstract] [Full Text]